Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Visweshwar

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Medical Oncology (Northwood, London, England)|September 26, 2020
A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancerDamian A Laber, Jennifer Eatrides, Michael V Jaglal, et al.
Journal of Clinical Medicine|August 7, 2021
Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single InstitutionConstantine N Logothetis, Ankita Patel, Jennifer Eatrides, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 22, 2022
Primary immune thrombocytopenia: a 'diagnosis of exclusion'?Nathan Visweshwar, Irmel Ayala, Michael Jaglal, et al.
Scientific Reports|November 4, 2020
Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trialsRuchi Desai, Gautam Krishna Koipallil, Nelson Thomas, et al.
Journal for Immunotherapy of Cancer|June 24, 2017
Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathyJose D Sandoval-Sus, Francis Mogollon-Duffo, Ankita Patel, et al.
Journal of Clinical Medicine|May 28, 2022
Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population-Bleeding Risk Factors in COVID-19 PatientsHesham Abowali, Antoinette Pacifico, Burak Erdinc, et al.
Cancers|June 28, 2023
Insights into the Impact of Hesitancy on Cancer Care and COVID-19Nathan Visweshwar, Juan Felipe Rico, Irmel Ayala, et al.
Journal of Clinical Medicine|August 29, 2024
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia VeraNathan Visweshwar, Bradley Fletcher, Michael Jaglal, et al.
European Journal of Haematology|November 20, 2023
Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective studyDamian A Laber, Parth C Patel, Constantine N Logothetis, et al.
Blood|October 23, 2023
Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta studyAndrew D Leavitt, Barbara A Konkle, Kimo C Stine, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Medical Oncology (Northwood, London, England)|September 26, 2020
A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancerDamian A Laber, Jennifer Eatrides, Michael V Jaglal, et al.
Journal of Clinical Medicine|August 7, 2021
Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single InstitutionConstantine N Logothetis, Ankita Patel, Jennifer Eatrides, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 22, 2022
Primary immune thrombocytopenia: a 'diagnosis of exclusion'?Nathan Visweshwar, Irmel Ayala, Michael Jaglal, et al.
Scientific Reports|November 4, 2020
Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trialsRuchi Desai, Gautam Krishna Koipallil, Nelson Thomas, et al.
Journal for Immunotherapy of Cancer|June 24, 2017
Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathyJose D Sandoval-Sus, Francis Mogollon-Duffo, Ankita Patel, et al.
Journal of Clinical Medicine|May 28, 2022
Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population-Bleeding Risk Factors in COVID-19 PatientsHesham Abowali, Antoinette Pacifico, Burak Erdinc, et al.
Cancers|June 28, 2023
Insights into the Impact of Hesitancy on Cancer Care and COVID-19Nathan Visweshwar, Juan Felipe Rico, Irmel Ayala, et al.
Journal of Clinical Medicine|August 29, 2024
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia VeraNathan Visweshwar, Bradley Fletcher, Michael Jaglal, et al.
European Journal of Haematology|November 20, 2023
Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective studyDamian A Laber, Parth C Patel, Constantine N Logothetis, et al.
Blood|October 23, 2023
Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta studyAndrew D Leavitt, Barbara A Konkle, Kimo C Stine, et al.
Pageof 3